TY - JOUR T1 - Treatment of hepatitis C virus with direct-acting antivirals: Practical aspects and current situation JO - Revista Clínica Española (English Edition) T2 - AU - Vivancos,M.J. AU - Moreno,A. AU - Quereda,C. SN - 22548874 M3 - 10.1016/j.rceng.2017.07.005 DO - 10.1016/j.rceng.2017.07.005 UR - https://revclinesp.es/en-treatment-hepatitis-c-virus-with-articulo-S2254887417301285 AB - Hepatitis C virus infection is a significant public health problem. The introduction of direct-acting antiviral agents, whose efficacy is greater than 90% in all patient groups (including those with cirrhosis), has represented a highly relevant change compared with classical interferon-based therapies. Tolerance for these antiviral agents is significantly better, and the treatment duration is shorter. This review updates the treatment of hepatitis C virus infection with the new direct-acting antiviral agents. ER -